Kim Holmstrøm

Dr. Kim Holmstrøm


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2004 in Anaerobe
Verified
Journal Article
Closed access
KHKim Holmstrøm
Kim Holmstrøm
MCMatthew D Collins
Matthew D Collins
TMTrine Møller
Trine Møller
EFEnevold Falsen
Enevold Falsen
PLPaul A Lawson
Paul A Lawson

27 April 2011 in Journal of Histochemistry & Cytochemistry
Verified
Journal Article
Open access
MSMartin J. Søe
Martin J. Søe
TMTrine Møller
Trine Møller
MDMartin Dufva
Martin Dufva
KHKim Holmstrøm
Kim Holmstrøm
The use of short, high-affinity probes consisting of a combination of DNA and locked nucleic acid (LNA) has enabled the specific detection of microRNAs (miRNAs) by in situ hybridization (ISH). However, detection of low–copy number miRNAs is still not always possible. Here the authors show that probes consisting of 2′-O-methyl RNAs (2OMe) and LNA at every third base (2:1 ratio), under optimized hybridization conditions, excluding yeast RNA from the hybridization buffer, can provide superior performance in detection of miRNA targets in terms of sensitivity and signal-to-noise ratio compared to DNA + LNA probes. Furthermore, they show that hybridizations can be performed in buffers of 4M urea instead of 50% formamide, thereby yielding an equally specific but nontoxic assay. The use of 2OMe + LNA–based probes and the optimized ISH assay enable simple and fast detection of low–copy number miRNA targets, such as miR-130a in mouse brain.

20 October 2017 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
RSRicardo J Soares
Ricardo J Soares
GMGiulia Maglieri
Giulia Maglieri
TGTony Gutschner
Tony Gutschner
SDSven Diederichs
Sven Diederichs
ALAnders H Lund
Anders H Lund
KHKim Holmstrøm
Kim Holmstrøm
Deciphering the functions of long non-coding RNAs (lncRNAs) is facilitated by visualization of their subcellular localization using in situ hybridization (ISH) techniques. We evaluated four different ISH methods for detection of MALAT1 and CYTOR in cultured cells: a multiple probe detection approach with or without enzymatic signal amplification, a branched-DNA (bDNA) probe and an LNA-modified probe with enzymatic signal amplification. All four methods adequately stained MALAT1 in the nucleus in all of three cell lines investigated, HeLa, NHDF and T47D, and three of the methods detected the less expressed CYTOR. The sensitivity of the four ISH methods was evaluated by image analysis. In all three cell lines, the two methods involving enzymatic amplification gave the most intense MALAT1 signal, but the signal-to-background ratios were not different. CYTOR was best detected using the bDNA method. All four ISH methods showed significantly reduced MALAT1 signal in knock-out cells, and siRNA-induced knock-down of CYTOR resulted in significantly reduced CYTOR ISH signal, indicating good specificity of the probe designs and detection systems. Our data suggest that the ISH methods allow detection of both abundant and less abundantly expressed lncRNAs, although the latter required the use of the most specific and sensitive probe detection system.

1 January 2010 in Human Immunology
Verified
Journal Article
Closed access
KHKim Holmstrøm
Kim Holmstrøm
APAyako Wakatsuki Pedersen
Ayako Wakatsuki Pedersen
MCMogens Helweg Claesson
Mogens Helweg Claesson
MZMai-Britt Zocca
Mai-Britt Zocca
SJSimon Skjøde Jensen
Simon Skjøde Jensen

Verified
Journal Article
Open access
PDF file
TMTrine Møller
Trine Møller
JJJaslin James
Jaslin James
KHKim Holmstrøm
Kim Holmstrøm
FSFlemming B Sørensen
Flemming B Sørensen
JLJan Lindebjerg
Jan Lindebjerg
BNBoye Schnack Nielsen
Boye Schnack Nielsen
MicroRNA-21 (miR-21) is upregulated in many cancers including colon cancers and is a prognostic indicator of recurrence and poor prognosis. In colon cancers, miR-21 is highly expressed in stromal fibroblastic cells and more weakly in a subset of cancer cells, particularly budding cancer cells. Exploration of the expression of inflammatory markers in colon cancers revealed tumor necrosis factor alpha (TNF-α) mRNA expression at the invasive front of colon cancers. Surprisingly, a majority of the TNF-α mRNA expressing cells were found to be cancer cells and not inflammatory cells. Because miR-21 is positively involved in cell survival and TNF-α promotes necrosis, we found it interesting to analyze the presence of miR-21 in areas of TNF-α mRNA expression at the invasive front of colon cancers. For this purpose, we developed an automated procedure for the co-staining of miR-21, TNF-α mRNA and the cancer cell marker cytokeratin based on analysis of frozen colon cancer tissue samples (n = 4) with evident cancer cell budding. In all four cases, TNF-α mRNA was seen in a small subset of cancer cells at the invasive front. Evaluation of miR-21 and TNF-α mRNA expression was performed on digital slides obtained by confocal slide scanning microscopy. Both co-expression and lack of co-expression with miR-21 in the budding cancer cells was noted, suggesting non-correlated expression. miR-21 was more often seen in cancer cells than TNF-α mRNA. In conclusion, we report that miR-21 is not linked to expression of the pro-inflammatory cytokine TNF-α mRNA, but that miR-21 and TNF-α both take part in the cancer expansion at the invasive front of colon cancers. We hypothesize that miR-21 may protect both fibroblasts and cancer cells from cell death directed by TNF-α paracrine and autocrine activity.

26 March 2019
Verified
Book Chapter
Closed access
PDF file
BNBoye Schnack Nielsen
Boye Schnack Nielsen
KHKim Holmstrøm
Kim Holmstrøm